naltrexone has been researched along with Affective Psychosis, Bipolar in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Gums, JG; McCoy, L; Monahan, C; Powell, J | 1 |
| Citrome, L; Faden, J; Serdenes, R | 1 |
| Corrao, MM; Nelson, LA | 1 |
| Gao, J; Li, J; Lu, X; Yang, J | 1 |
| Paik, J | 1 |
| Babb, SM; Cohen, BM; Murphy, BL; Ravichandran, C | 1 |
| Dowling, NA; Lorains, FK; Merkouris, SS | 1 |
| Adinoff, B; Brown, ES; Caetano, R; Carmody, TJ; John Rush, A; Schmitz, JM; Swann, AC | 1 |
| Dundon, WD; O'Brien, CP; Pettinati, HM | 1 |
| Kircher, T; Kluge, I; Konrad, C; Losekam, S; Nittel, KS | 1 |
| Grant, JE; Grosz, R | 1 |
| Beard, L; Brown, ES; Dobbs, L; Rush, AJ | 1 |
| Carroll, K; Levinson, C; Nich, C; Petrakis, I; Poling, J; Ralevski, E; Rounsaville, B | 1 |
| Volavka, J | 1 |
| Buchsbaum, MS; Davis, GC | 1 |
| Martin, WR; McNicholas, LF | 1 |
| Brady, KT; Sonne, SC | 1 |
7 review(s) available for naltrexone and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Naltrexone; Olanzapine; Schizophrenia | 2022 |
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Naltrexone; Narcotic Antagonists; Olanzapine; Schizophrenia; Tablets; Weight Gain | 2022 |
Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
Topics: Analgesics, Opioid; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Naltrexone; Olanzapine; Schizophrenia; Weight Gain | 2022 |
Olanzapine/Samidorphan: First Approval.
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Combinations; Humans; Naltrexone; Narcotic Antagonists; Olanzapine; Schizophrenia; Weight Gain | 2021 |
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar Disorder; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Free Radical Scavengers; Gambling; Humans; Lithium Compounds; Mental Disorders; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tobacco Use Disorder | 2016 |
Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Topics: Alcoholism; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Controlled Clinical Trials as Topic; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Drug Therapy, Combination; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Psychotropic Drugs; Sertraline; Substance-Related Disorders | 2013 |
New and experimental therapeutic roles for naloxone and related opioid antagonists.
Topics: Alcohol Deterrents; Animals; Bipolar Disorder; Blood Pressure; Brain Ischemia; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Respiration; Schizophrenia; Shock; Spinal Injuries | 1984 |
5 trial(s) available for naltrexone and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Young Adult | 2014 |
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
Topics: Adult; Affect; Alcoholism; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Psychiatric Status Rating Scales; Regression Analysis; Survival Analysis | 2009 |
Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Topics: Alcohol Deterrents; Alcoholism; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Connecticut; Depressive Disorder, Major; Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Gastrointestinal Diseases; Humans; Male; Massachusetts; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2007 |
Action of naloxone and naltrexone in different types of psychoses.
Topics: Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Endorphins; Humans; Naloxone; Naltrexone; Psychotic Disorders; Receptors, Opioid; Schizophrenia | 1981 |
New and experimental therapeutic roles for naloxone and related opioid antagonists.
Topics: Alcohol Deterrents; Animals; Bipolar Disorder; Blood Pressure; Brain Ischemia; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Respiration; Schizophrenia; Shock; Spinal Injuries | 1984 |
6 other study(ies) available for naltrexone and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Samidorphan for the treatment of weight gain associated with olanzapine in patients with schizophrenia and bipolar disorder.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Naltrexone; Narcotic Antagonists; Olanzapine; Schizophrenia; Weight Gain | 2022 |
Letter to the Editor: Shopping frenzy induced by naltrexone--a paradoxical effect in bipolar disorder?
Topics: Bipolar Disorder; Compulsive Behavior; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 2013 |
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation.
Topics: Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Personality Assessment; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Naltrexone in patients with bipolar disorder and alcohol dependence.
Topics: Adult; Alcoholism; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Pilot Projects; Psychiatric Status Rating Scales; Psychotropic Drugs; Secondary Prevention; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 2006 |
Pain sensitivity and endorphins in functional psychoses.
Topics: Bipolar Disorder; Depressive Disorder; Endorphins; Evoked Potentials, Somatosensory; Female; Humans; Male; Naltrexone; Nociceptors; Pain; Psychotic Disorders; Receptors, Opioid; Schizophrenic Psychology; Sensory Thresholds | 1981 |
Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence.
Topics: Adult; Alcoholism; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Naltrexone; Narcotic Antagonists; Nausea | 2000 |